RSS-Feed abonnieren
DOI: 10.1055/s-0039-1693631
Evaluation of Postprocedural Pain and Quality-of-Life Improvement in Rural Patients with Chronic Venous Insufficiency Undergoing Endovenous Laser Ablation
Publikationsverlauf
Received: 25. Februar 2019
Accepted after revision: 15. Mai 2019
Publikationsdatum:
18. Juli 2019 (online)
Abstract
Background Chronic venous insufficiency (CVI) manifests as unilateral or bilateral lower-limb venous hypertension causing pain, swelling, edema, and skin changes, among other symptoms. CVI affects patients’ socioeconomic status, is particularly seen in the young, and, in its severe manifestation, may have a debilitating effect on patients’ quality of life (QoL). The authors wanted to evaluate change in pain and QoL among rural patients after endovenous laser ablation (EVLA) treatment in a pilot study.
Methods Twenty patients having CVI who opted for 1,470-nm EVLA treatment were enrolled at the Interventional Radiology department between July 2018 and September 2018. The authors evaluated pain using the visual analog scale (VAS) before and after EVLA procedure (standard protocol) of the affected vein. They also assessed QoL using the Aberdeen Varicose Vein Questionnaire before and 6 weeks after EVLA.
Results The authors observed significant reduction in pain postprocedure versus preprocedure. Majority of the patients had improvement in itching and stasis dermatitis after the procedure. Rash and skin ulcers remained uncommon before and after EVLA. Also, after EVLA, fewer patients than before reported that the appearance of their diseased veins caused them concern (35 vs. 65% before EVLA), influenced their choice of clothing (45 vs. 80%), interfered with their work (40 vs. 90%), and interfered with their leisure activities (30 vs. 80%).
Conclusion EVLA 1470nm procedure may help patients with CVI attain improved QoL and significant pain reduction.
-
References
- 1 Ravikumar BL, Satish KumarR, Francisco Menezes JV, Jain A. Our experience in the management of varicose veins of the lower limb. J Evol Med Dent Sci 2014; 3 (16) 4137-4144
- 2 Adhikari A, Criqui MH, Wooll V. et al. The epidemiology of chronic venous diseases. Phlebology 2000; 15 (01) 2-18
- 3 Mohan A, Banode P, Sharma G. Chronic venous insufficiency: a study of clinical presentation at a rural hospital and its management in Interventional Radiology clinic. Int J Sci Res (Ahmedabad) 2018; 7 (06) 3-6
- 4 Rabe E, Hertel S, Bock E, Hoffmann B, Jöckel K-H, Pannier F. Therapy with compression stockings in Germany - results from the Bonn Vein Studies. J Dtsch Dermatol Ges 2013; 11 (03) 257-261
- 5 Callam MJ. Epidemiology of varicose veins. Br J Surg 1994; 81 (02) 167-173
- 6 Mirji P, Emmi S, Joshi C. Study of clinical features and management of varicose veins of lower limb. J Clin Diagn Res 2011; 5 (07) 1416-1420
- 7 Kistner RL, Eklof B, Masuda EM. Diagnosis of chronic venous disease of the lower extremities: the “CEAP” classification. Mayo Clin Proc 1996; 71 (04) 338-345
- 8 Labropoulos N. CEAP in clinical practice. Vasc Surg 1997; 31 (03) 224-225
- 9 Bradbury A, Evans C, Allan P, Lee A, Ruckley CV, Fowkes FG. What are the symptoms of varicose veins?. Edinburgh vein study cross sectional population survey. BMJ 1999; 318 7180 353-356
- 10 Vasudevan B. Venous leg ulcers: pathophysiology and classification. Indian Dermatol Online J 2014; 5 (03) 366-370
- 11 Golledge J, Quigley FG. Pathogenesis of varicose veins. Eur J Vasc Endovasc Surg 2003; 25 (04) 319-324
- 12 Carroll C, Hummel S, Leaviss J. et al. Clinical effectiveness and cost-effectiveness of minimally invasive techniques to manage varicose veins: a systematic review and economic evaluation. Health Technol Assess 2013; 17 (48) i-xvi 1–141
- 13 Eklöf B, Rutherford RB, Bergan JJ. et al; American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004; 40 (06) 1248-1252
- 14 Min RJ, Khilnani N, Zimmet SE. Endovenous laser treatment of saphenous vein reflux: long-term results. J Vasc Interv Radiol 2003; 14 (08) 991-996
- 15 Torrance GW, Feeny D, Furlong W. Visual analog scales: do they have a role in the measurement of preferences for health states?. Med Decis Making 2001; 21 (04) 329-334
- 16 Garratt AM, Macdonald LM, Ruta DA, Russell IT, Buckingham JK, Krukowski ZH. Towards measurement of outcome for patients with varicose veins. Qual Health Care 1993; 2 (01) 5-10
- 17 Staniszewska A, Cotton S, MacLennan G, Brittenden J. Modifying a validated instrument: the Aberdeen varicose vein questionnaire. Trials 2015; 16 (02) 56
- 18 Rosner B, Glynn RJ, Lee M-LT. The Wilcoxon signed rank test for paired comparisons of clustered data. Biometrics 2006; 62 (01) 185-192
- 19 Navarro L, Min RJ, Boné C. Endovenous laser: a new minimally invasive method of treatment for varicose veins—preliminary observations using an 810 nm diode laser. Dermatol Surg 2001; 27 (02) 117-122
- 20 Galanopoulos G, Lambidis C. Minimally invasive treatment of varicose veins: Endovenous laser ablation (EVLA). Int J Surg 2012; 10 (03) 134-139
- 21 Weiss RA, Weiss MA. Controlled radiofrequency endovenous occlusion using a unique radiofrequency catheter under duplex guidance to eliminate saphenous varicose vein reflux: a 2-year follow-up. Dermatol Surg 2002; 28 (01) 38-42
- 22 Doganci S, Demirkilic U. Comparison of 980 nm laser and bare-tip fibre with 1470 nm laser and radial fibre in the treatment of great saphenous vein varicosities: a prospective randomised clinical trial. Eur J Vasc Endovasc Surg 2010; 40 (02) 254-259
- 23 Coupland A, Stansby G. Glue for superficial venous ablation. Rev Vac Med 2014; 2 (03) 98-102
- 24 Disselhoff BC, der Kinderen DJ, Kelder JC, Moll FL. Five-year results of a randomised clinical trial of endovenous laser ablation of the great saphenous vein with and without ligation of the saphenofemoral junction. Eur J Vasc Endovasc Surg 2011; 41 (05) 685-690
- 25 Houtermans-Auckel JP, van Rossum E, Teijink JA. et al. To wear or not to wear compression stockings after varicose vein stripping: a randomised controlled trial. Eur J Vasc Endovasc Surg 2009; 38 (03) 387-391
- 26 Lattimer CR, Kalodiki E, Azzam M, Geroulakos G. Responsiveness of individual questions from the venous clinical severity score and the Aberdeen varicose vein questionnaire. Phlebology 2014; 29 (01) 43-51
- 27 Klem TM, Sybrandy JE, Wittens CH. Measurement of health-related quality of life with the Dutch translated Aberdeen Varicose Vein Questionnaire before and after treatment. Eur J Vasc Endovasc Surg 2009; 37 (04) 470-476
- 28 Kuet M-L, Lane TR, Anwar MA, Davies AH. Comparison of disease-specific quality of life tools in patients with chronic venous disease. Phlebology 2014; 29 (10) 648-653
- 29 Mariani F. Lower-limb venous symptoms and assessment of quality of life: existing tools. Medicographia [Internet]. Available at: https://www.medicographia.com/2015/06/lower-limb-venous-symptoms-and-assessment-of-quality-of-life-existing-tools/ Accessed April 20, 2019
- 30 Lacci KM, Dardik A. Platelet-rich plasma: support for its use in wound healing. Yale J Biol Med 2010; 83 (01) 1-9
- 31 Dunst KM, Huemer GM, Wayand W, Shamiyeh A. Diffuse phlegmonous phlebitis after endovenous laser treatment of the greater saphenous vein. J Vasc Surg 2006; 43 (05) 1056-1058